PETRALIA, GIUSEPPE
PETRALIA, GIUSEPPE
Dipartimento di Oncologia ed Emato-Oncologia
[18F]FDG positron emission tomography/computed tomography and multidetector computed tomography roles in thymic lesion treatment planning
2008 L .L. Travaini, G. Petralia, G. Trifirò, L. Ravasi, D. Galetta, G. Carbone, F. Falcini, L. Spaggiari, M. Bellomi, G. Paganelli
A global Unified Dosimetry Index (gUDI) to evaluate simultaneous integrated boost radiotherapy plans in prostate cancer
2018 M. Mambretti, C. Romanò, G. Marvaso, S. Comi, R. Cambria, D. Ciardo, F. Emiro, C. Fodor, D. Zerini, G. Riva, G. Petralia, O. De Cobelli, R. Orecchia, F. Cattani, B.A. Jereczek
A novel nomogram predicting lymph node invasion among patients with prostate cancer: The importance of extracapsular extension at multiparametric magnetic resonance imaging
2021 E. Di Trapani, S. Luzzago, G. Peveri, M. Catellani, M. Ferro, G. Cordima, F.A. Mistretta, R. Bianchi, G. Cozzi, S. Alessi, D.V. Matei, V. Bagnardi, G. Petralia, G. Musi, O. De Cobelli
A novel nomogram to identify candidates for active surveillance among patients with ISUP Grade Group 1 or ISUP Grade Group 2 prostate cancer, according to multiparametric magnetic resonance imaging findings
2020 S. Luzzago, O. de Cobelli, G. Cozzi, G. Peveri, V. Bagnardi, M. Catellani, E. Di Trapani, F.A. Mistretta, P. Pricolo, A. Conti, S. Alessi, G. Marvaso, M. Ferro, D. Matei, G. Renne, B. Jereczek-Fossa, G. Petralia, G. Musi
Active surveillance for prostate cancer: comparison between incidental tumors vs. tumors diagnosed at prostate biopsies
2021 S. Luzzago, M.L. Piccinelli, G. Marvaso, E. Laukhtina, N. Miura, V.M. Schuettfort, K. Mori, A. Aydh, M. Ferro, F.A. Mistretta, N. Fusco, G. Petralia, B.A. Jereczek-Fossa, S.F. Shariat, P.I. Karakiewicz, O. de Cobelli, G. Musi
Anterior prostatic tumours are difficult to diagnose without MRI
2012 G. Petralia, S. Alessi, A. Alconchel, P. Summers, G. Musi, V. Matei, O. de Cobelli, G. Renne, M. Bellomi
Apparent Diffusion Coefficient and Other Preoperative Magnetic Resonance Imaging Features for the Prediction of Positive Surgical Margins in Prostate Cancer Patients Undergoing Radical Prostatectomy
2021 S. Alessi, R. Maggioni, S. Luzzago, A. Colombo, P. Pricolo, P.E. Summers, G. Saia, M. Manzoni, G. Renne, G. Marvaso, O. De Cobelli, M. Bellomi, B.A. Jereczek-Fossa, G. Petralia
Association between previous negative biopsies and lower rates of progression during active surveillance for prostate cancer
2022 M.L. Piccinelli, S. Luzzago, G. Marvaso, E. Laukhtina, N. Miura, V.M. Schuettfort, K. Mori, A. Colombo, M. Ferro, F.A. Mistretta, N. Fusco, G. Petralia, B.A. Jereczek-Fossa, S.F. Shariat, P.I. Karakiewicz, O. de Cobelli, G. Musi
Baseline Multiparametric MRI for Selection of Prostate Cancer Patients Suitable for Active Surveillance : Which Features Matter?
2018 F. Sanguedolce, G. Petralia, H. Sokhi, E. Tagliabue, N. Anyamene, G. Hellawell, A.R. Padhani
Breast MR with special focus on DW-MRI and DCE-MRI
2011 G. Petralia, L. Bonello, F. Priolo, P. Summers, M. Bellomi
Capecitabine initially concomitant to radiotherapy then perioperatively administered in locally advanced rectal cancer
2009 M.C. Zampino, E. Magni, M.C. Leonardi, E. Petazzi, L. Santoro, F. Luca, A. Chiappa, G. Petralia, C. Trovato, N. Fazio, R. Orecchia, F. Nolè, F. de Braud
Clinical evaluation and disease management of PI-RADS 3 lesions. Analysis from a single tertiary high-volume center
2020 E. Di Trapani, G. Musi, M. Ferro, G. Cordima, F.A. Mistretta, S. Luzzago, R. Bianchi, G. Cozzi, S. Alessi, M. Catellani, D.V. Matei, B.A. Jereczek-Fossa, G. Petralia, O. De Cobelli
Clinical outcomes and radio-biological features correlation in early pca: An exploratory analysis
2021 G. Corrao, G. Marvaso, M. Zaffaroni, C.I. Fodor, S. Volpe, L. Bergamaschi, D. Zerini, A. Vingiani, G. Petralia, S. Alessi, P. Pricolo, G. Renne, R. Orecchia, B.A. Jereczek-Fossa
Combined ultrasmall superparamagnetic particles of iron oxide-enhanced and diffusion-weighted magnetic resonance imaging facilitates detection of metastases in normal-sized pelvic lymph nodes of patients with bladder and prostate cancer
2013 F.D. Birkhäuser, U.E. Studer, J.M. Froehlich, M. Triantafyllou, L.J. Bains, G. Petralia, P. Vermathen, A. Fleischmann, H.C. Thoeny
Comparison of whole-body diffusion-weighted magnetic resonance and FDG-PET/CT in the assessment of Hodgkin's lymphoma for staging and treatment response
2014 J. Montoro, D. Laszlo, N.P.C. Zing, G. Petralia, G. Conte, M. Colandrea, G. Martinelli, L. Preda
Concurrent cisplatin, continuous infusion fluorouracil and radiotherapy followed by tailored consolidation treatment in non metastatic anal squamous cell carcinoma
2011 M.G. Zampino, E. Magni, M.C. Leonardi, L. Santoro, E. Petazzi, C. Fodor, G. Petralia, C. Trovato, F. Nolè, R. Orecchia
Confirmatory multiparametric magnetic resonance imaging at recruitment confers prolonged stay in active surveillance and decreases the rate of upgrading at follow-up
2019 S. Luzzago, M. Catellani, E. Di Trapani, G. Cozzi, F.A. Mistretta, R. Bianchi, P. Pricolo, A. Conti, E. Ancona, N. Piacentini, S. Alessi, G. Renne, M. Ferro, D.V. Matei, G. Musi, B. Alicja Jereczek-Fossa, G. Petralia, O. de Cobelli
Contrast-enhanced ultrasound sonography optimises the assessment of lymph nodes in oncology
2013 G. Petralia, G. Conte, E. De Fiori, S. Alessi, M. Bellomi
Correction: Confirmatory multiparametric magnetic resonance imaging at recruitment confers prolonged stay in active surveillance and decreases the rate of upgrading at follow-up (Prostate Cancer and Prostatic Diseases, (2020), 23, 1, (94-101), 10.1038/s41391-019-0160-3)
2020 S. Luzzago, M. Catellani, E. Di Trapani, G. Cozzi, F.A. Mistretta, R. Bianchi, P. Pricolo, A. Conti, E. Ancona, N. Piacentini, S. Alessi, G. Renne, M. Ferro, D.-. Matei, G. Musi, B.A. Jereczek-Fossa, G. Petralia, O. de Cobelli
Correlation between CT perfusion and clinico-pathological features in prostate cancer: a prospective study
2015 E. Łuczyńska, S. Heinze Paluchowska, P. Blecharz, B. Jereczek-Fossa, G. Petralia, M. Bellomi, A. Stelmach